A MULTICENTER STUDY TO EVALUATE THE SAFETY...

6

Transcript of A MULTICENTER STUDY TO EVALUATE THE SAFETY...

Page 1: A MULTICENTER STUDY TO EVALUATE THE SAFETY ...mjiri.iums.ac.ir/.../admin-A-10-1-253-6f98c75.pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il. End-of-treatment
Page 2: A MULTICENTER STUDY TO EVALUATE THE SAFETY ...mjiri.iums.ac.ir/.../admin-A-10-1-253-6f98c75.pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il. End-of-treatment
Page 3: A MULTICENTER STUDY TO EVALUATE THE SAFETY ...mjiri.iums.ac.ir/.../admin-A-10-1-253-6f98c75.pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il. End-of-treatment
Page 4: A MULTICENTER STUDY TO EVALUATE THE SAFETY ...mjiri.iums.ac.ir/.../admin-A-10-1-253-6f98c75.pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il. End-of-treatment
Page 5: A MULTICENTER STUDY TO EVALUATE THE SAFETY ...mjiri.iums.ac.ir/.../admin-A-10-1-253-6f98c75.pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il. End-of-treatment
Page 6: A MULTICENTER STUDY TO EVALUATE THE SAFETY ...mjiri.iums.ac.ir/.../admin-A-10-1-253-6f98c75.pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il. End-of-treatment

Hepatitis web study Hepatitis web study Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase 2a, Treatment Naïve and Treatment Experienced.

Hepatitis web study Hepatitis web study Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase 2a, Treatment Naïve and Treatment Experienced.

Antiviral Approaches Against HCV PEG-INF + Ribavirin Therapy. Host / Viral Factors Affecting Treatment Response. Adverse Effect of Therapy. Sofosbuvir.

Antiviral Approaches Against HCV PEG-INF + Ribavirin Therapy. Host / Viral Factors Affecting Treatment Response. Adverse Effect of Therapy. Sofosbuvir.

Response to peg-interferon and ribavirin for the treatment ... · Study Title: Response to peg-interferon and ribavirin for the treatment of HCV infection in HIV co-infected patients,

Response to peg-interferon and ribavirin for the treatment ... · Study Title: Response to peg-interferon and ribavirin for the treatment of HCV infection in HIV co-infected patients,

Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin in HCV Genotype 1 NIH SPARE Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics)

Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin in HCV Genotype 1 NIH SPARE Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics)

Hepatitis web study Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotypes 1-3 A1444-040 Trial Phase 2a Treatment Naïve and Treatment.

Hepatitis web study Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotypes 1-3 A1444-040 Trial Phase 2a Treatment Naïve and Treatment.

Hepatitis web study Hepatitis web study Peginterferon alfa-2b + Ribavirin in GT 1-6 (Flat versus Weight-Based Ribavirin Dosing) WINR Study Phase 3 Treatment.

Hepatitis web study Hepatitis web study Peginterferon alfa-2b + Ribavirin in GT 1-6 (Flat versus Weight-Based Ribavirin Dosing) WINR Study Phase 3 Treatment.

Treatment Naïve and Treatment Experienced · COSMOS Trial: Study Features COSMOS Trial: Features Design: Randomized, phase 2a, open-label, using sofosbuvir + simeprevir +/- ribavirin

Treatment Naïve and Treatment Experienced · COSMOS Trial: Study Features COSMOS Trial: Features Design: Randomized, phase 2a, open-label, using sofosbuvir + simeprevir +/- ribavirin

CARE AND TREATMENT OF CHRONIC HBV AND HCV … · Chronic HBV and HCV are treatable or curable HBV Treatment HCV Treatment Interferon alfa-2b Interferon-alfa-2a/2b ± ribavirin Lamivudine

CARE AND TREATMENT OF CHRONIC HBV AND HCV … · Chronic HBV and HCV are treatable or curable HBV Treatment HCV Treatment Interferon alfa-2b Interferon-alfa-2a/2b ± ribavirin Lamivudine

PRODUCT INFORMATION REBETOL (ribavirin, USP) Capsules

PRODUCT INFORMATION REBETOL (ribavirin, USP) Capsules

Sofosbuvir, Ribavirin, GS - 0938 QUANTUM

Sofosbuvir, Ribavirin, GS - 0938 QUANTUM

Hepatitis C (Direct Acting Antiviral Medications for Treatment of …Direct_Acting... · who failed prior treatment with peginterferon alfa (PEG-IFN) and ribavirin (RBV) with or without

Hepatitis C (Direct Acting Antiviral Medications for Treatment of …Direct_Acting... · who failed prior treatment with peginterferon alfa (PEG-IFN) and ribavirin (RBV) with or without

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment … · 2017. 8. 28. · combination with peginterferon and ribavirin, yield improved SVR rates compared with peginterferon

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment … · 2017. 8. 28. · combination with peginterferon and ribavirin, yield improved SVR rates compared with peginterferon

Deterioration of subclinical atherosclerosis markers ... · Deterioration of subclinical atherosclerosis markers during and after pegylated interferon and ribavirin treatment for

Deterioration of subclinical atherosclerosis markers ... · Deterioration of subclinical atherosclerosis markers during and after pegylated interferon and ribavirin treatment for

Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers ...

Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers ...

Hepatitis web study Hepatitis web study Ledipasvir + Sofosbuvir +/- Ribavirin in GT 1-3 ELECTRON 2 Phase 2 Treatment Naïve and Treatment Experienced Source:

Hepatitis web study Hepatitis web study Ledipasvir + Sofosbuvir +/- Ribavirin in GT 1-3 ELECTRON 2 Phase 2 Treatment Naïve and Treatment Experienced Source:

Hepatitis C and B, and the rest of the alphabet · 2007-07-23 · Pegylated interferon α-2b plus ribavirin compared with interferon α2b plus ribavirin for the initial treatment

Hepatitis C and B, and the rest of the alphabet · 2007-07-23 · Pegylated interferon α-2b plus ribavirin compared with interferon α2b plus ribavirin for the initial treatment

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in · PDF fileAccepted Manuscript Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in · PDF fileAccepted Manuscript Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights … · Treatment-experienced adult and pediatric subjects have failed a peginterferon alfa +/- ribavirin based regimen with

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights … · Treatment-experienced adult and pediatric subjects have failed a peginterferon alfa +/- ribavirin based regimen with

2014 Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome co

2014 Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome co